10/31/2022 0 Comments After effects of covid vaccine![]() ![]() The J&J vaccine has also been associated with the rare blood clotting disorder thrombosis with thrombocytopenia syndrome (TTS). Johnson & Johnson, Covid-19 Vaccine Janssen PRAC is also currently assessing whether glomerulonephritis, nephrotic syndrome and erythema multiforme could be side effects of the Spikevax vaccine. A source said data from Canada has suggested young people getting the Moderna vaccine – especially males under the age of around 30 – may carry a higher risk of myocarditis than those Who receive the Pfizer-BioNTech jab. Moderna, SpikevaxĪs well as the Pfizer vaccine, the EMA has also concluded a possible causal link between Moderna ’s Spikevax and cases of myocarditis and pericarditis, and recommended they are listed as potential side effects of the jab.Īccording to the Washington Post, the jab is yet to be authorised for adolescents due to FDA concerns that it may be associated with a higher risk of myocarditis than previously thought. Glomerulonephritis, inflammation of filters within the kidneys, and nephrotic syndrome, a disorder causing the kidneys to leak excessive protein in the urine, are also being assessed by PRAC as potential side effects of Comirnaty. #After effects of covid vaccine skinPRAC is currently investigating reports of erythema multiforme, an allergic skin reaction, to establish whether it is a side effect of the Pfizer vaccine. At the time, over 177 million doses of Comirnaty had been administered in the EEA. The PRAC has recommended updating the vaccine’s product information to include the conditions as potential side effects, after reviewing 145 cases of myocarditis and 138 cases of pericarditis in those Who had received the Pfizer vaccine in the European Economic Area (EEA). The EMA has said there is a possible link between Comirnaty and very rare cases of the inflammatory heart conditions myocarditis and pericarditis. It said that a causal relationship between the vaccine and the disorder was “at least a reasonable possibility”. In September, the European Medicines Agency officially listed GBS as a possible, very rare side effect of Vaxzevria. GBS is a rare immune system disorder that can cause pain, muscle weakness and difficulty walking, and was identified during the jab’s marketing authorisation process as a possible adverse event that requires specific safety monitoring. PRAC said in July that the product information for Vaxzevria should include a warning of cases of Guillain-Barré syndrome (GBS) reported after vaccination. The Committee also said capillary leak syndrome should be listed as a new side effect of the vaccine, after reviewing six cases of the condition in people Who had received the AstraZeneca jab, including one person Who died. The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) has also concluded that people Who have previously had capillary leak syndrome, a rare but serious condition that causes fluid leakage from small blood vessels, must not be vaccinated with Vaxzevria. The EMA maintains that the benefit of the vaccine outweighs its risk of blood clots – and it is important to note that the risk of blood clots is far higher in those Who catch Covid-19. What are the potential growth opportunities?.How might the Chinese government react?.Spotlight on Shanghai: what is the situation there?.What is the effect of lockdowns on Chinese ports?. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |